Stock 000597 NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Northeast Pharmaceutical Group Co., Ltd.

Equities

000597

CNE0000009G0

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
4.75 CNY +1.93% Intraday chart for Northeast Pharmaceutical Group Co., Ltd. +1.50% -11.21%
25/04 Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
29/03 Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Northeast Pharmaceutical Group Co., Ltd. specializes in the production and marketing of pharmaceutical ingredients and preparations. The group's products include antibiotics, vitamins, cardiovascular treatments, anesthetics, medical plants, etc.

China accounts for 86.3% of net sales.

Number of employees: 6,214

Sales per Business

CNY in Million2022Weight2023Weight Delta
Other
42.9 %
3,745 42.5 % 3,539 42.9 % -5.52%
Preparation
41.3 %
3,593 40.8 % 3,408 41.3 % -5.15%
Raw Material
15.7 %
1,470 16.7 % 1,296 15.7 % -11.84%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
8,809 100.0 % 8,243 100.0 % -6.42%

Managers

Managers TitleAgeSince
Kai Zhou CEO
 Chief Executive Officer 60 01/05/01
Yang Cai SEC
 Corporate Secretary 39 08/19/08

Members of the board

Members of the board TitleAgeSince
Li Qin Chen BRD
 Director/Board Member 59 17/21/17
Kai Zhou CEO
 Chief Executive Officer 60 01/05/01
Zhao Chun Tan BRD
 Director/Board Member 59 17/21/17
Zhi Hua Huang BRD
 Director/Board Member 56 17/21/17
Cheng Ren Huang BRD
 Director/Board Member 60 18/18/18
Xin Hua Ao BRD
 Director/Board Member 60 18/18/18
Demin Han BRD
 Director/Board Member 73 18/18/18
Hui Yao BRD
 Director/Board Member 60 18/18/18
Bai Dan Zhan CHM
 Chairman 50 27/18/27
Jian Min Guo CHM
 Chairman 53 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,429,103,265 596,135,801 ( 41.71 %) 40,765,000 ( 2.852 %) 41.71 %

Shareholders

NameEquities%Valuation
Wei Fang
58.69 %
784,489,285 58.69 % 518 M ¥
China Huarong Asset Management Co., Ltd. (Invt Port)
3.240 %
43,309,294 3.240 % 29 M ¥
En Bo Wu
0.7023 %
9,387,000 0.7023 % 6 M ¥
Jian Peng
0.3000 %
4,010,200 0.3000 % 3 M ¥
Da Peng Liu
0.2998 %
4,007,100 0.2998 % 3 M ¥
Pei Hua Gao
0.2811 %
3,757,278 0.2811 % 2 M ¥
Xu Dong Tang
0.2766 %
3,696,798 0.2766 % 2 M ¥
Fullgoal Fund Management Co., Ltd.
0.1225 %
1,637,500 0.1225 % 1 M ¥
Kai Zhou
0.0789 %
1,055,025 0.0789 % 696 295 ¥
China Asset Management Co., Ltd.
0.0724 %
967,730 0.0724 % 638 682 ¥
NameEquities%Valuation
Kai Zhou
3.241 %
3,165,075 3.241 % 2 M ¥
Jing Cheng Sun
2.003 %
1,956,231 2.003 % 1 M ¥

Company contact information

Northeast Pharmaceutical Group Co., Ltd.

Shenyang Economics & Tech Dev Zone 8, Kunming Lake Street

110027, Shenyang

+86 24 2580 6963

http://www.nepharm.com.cn
address Northeast Pharmaceutical Group Co., Ltd.(000597)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
NORTHEAST PHARMACEUTICAL GROUP CO., LTD. Stock Northeast Pharmaceutical Group Co., Ltd.
-11.21% 938M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.69% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000597 Stock
  4. Company Northeast Pharmaceutical Group Co., Ltd.